SCHEMBL22101217

SCHEMBL22101217

CCNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 17/20 0.70
GABRP O00591 1/20 0.70
GABRD O14764 1/20 0.70
NR1I2 O75469 1/20 0.70
NR3C1 P04150 1/20 0.70
PGR P06401 1/20 0.70
KLK3 P07288 1/20 0.70
GABRA1 P14867 1/20 0.70
GABRB1 P18505 1/20 0.70
GABRG2 P18507 1/20 0.70
CNR1 P21554 1/20 0.70
TBXA2R P21731 1/20 0.70
GABRB3 P28472 1/20 0.70
GABRA5 P31644 1/20 0.70
GABRA3 P34903 1/20 0.70
GABRA2 P47869 1/20 0.70
GABRB2 P47870 1/20 0.70
GABRA4 P48169 1/20 0.70
GABRE P78334 1/20 0.70
GABRA6 Q16445 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20465765 0.92 AR (0.83) ARGABRPGABRDNR1I2NR3C1
SCHEMBL582006 0.85 AR (0.80) ARGABRPGABRDNR1I2NR3C1
SCHEMBL23378335 0.84 AR (0.81) ARGABRPGABRDNR1I2NR3C1
SCHEMBL582695 0.84 AR (0.81) ARGABRPGABRDNR1I2NR3C1
SCHEMBL7035063 0.84 AR (0.87) ARGABRPGABRDNR1I2NR3C1
SCHEMBL31071654 0.83 AR (0.71) ARGABRPGABRDNR1I2NR3C1
SCHEMBL22117698 0.83 AR (0.71) ARGABRPGABRDNR1I2NR3C1
SCHEMBL21788386 0.82 AR (0.87) ARGABRPGABRDNR1I2NR3C1
Enzalutamide SCHEMBL189749 0.82 AR (1.00) ARGABRPGABRDNR1I2NR3C1
Enzalutamide SCHEMBL29352764 0.82 AR (1.00) ARGABRPGABRDNR1I2NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3666772-A1 DIARYLTHIOHYDANTOIN COMPOUND AS ANDROGEN RECEPTOR ANTAGONIST Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2020-06-17 EP disclosed